Sun Pharma to acquire Organon in $11.75 billion all-cash deal
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The summit brought together over 150 doctors, researchers, and practitioners worldwide
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Growth was broad-based across segments
The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Subscribe To Our Newsletter & Stay Updated